RIV Capital (TSE:RIV) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
RIV Capital Inc. and Cansortium Inc. have received approval from the New York Cannabis Control Board for their business combination, with expected closure in Q4 of 2024. This merger aims to create a leading multistate cannabis platform, leveraging RIV’s current momentum from adult-use sales and Cansortium’s medical program expertise to meet the rising demand in New York.
For further insights into TSE:RIV stock, check out TipRanks’ Stock Analysis page.
